WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and ...
Pharmaceutical Technology on MSN
High-dose biologic delivery to become industry standard
As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.
HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading ...
WuXi Biologics says the company will provide the partnership with integrated, end-to-end biologics development and manufacturing services.
BioDlink, a leading global contract development and manufacturing organization (CDMO), has released a white paper titled ...
Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of ...
Explore the connection between neurodegeneration and cellular senescence in understanding brain structure and ageing.
The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions ...
Researchers have discovered a biological switch that explains why movement keeps bones strong. The protein senses physical ...
XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results